Getting Mounjaro on the NHS in Wales: The Real Picture

The myth worth correcting first: NICE approval doesn't mean NHS Wales will prescribe it

A widespread assumption is that once NICE issues a positive recommendation, the medicine becomes available across the NHS in the UK. That isn't how it works for Wales. NICE technology appraisals (including TA1026, which recommended tirzepatide for weight management in December 2024) are legally binding on NHS England and NHS Wales, but the commissioning pathways and timelines differ. In practice, NHS Wales adopts NICE decisions in stages, and the specific NHS England implementation plan (with phased cohort criteria) does not automatically translate into identical Welsh provision on the same timetable.

NHS Wales has its own medicines appraisal body, the All Wales Medicines Strategy Group (AWMSG), and weight-management commissioning decisions are made by Local Health Boards. At the time of writing, tirzepatide has not been incorporated into a funded NHS Wales weight-management pathway. That means a GP in Wales cannot currently prescribe Mounjaro for weight loss on the NHS, even if you meet the clinical criteria that would apply in England. Worth being clear about that distinction before pursuing a referral.

If you want to keep track of what's available through NHS Wales for Mounjaro specifically, your Local Health Board is the right place to look, or ask your GP directly whether a referral to a specialist weight-management service is currently possible in your area.

What NHS Wales does offer for weight management, and where Mounjaro fits

NHS Wales does commission specialist weight-management services, and semaglutide (Wegovy) has been recommended by NICE under TA875 for use within specialist services with multidisciplinary support. Whether a particular Local Health Board has fully activated that pathway is another question; waiting lists for tier 3 weight-management services in Wales can be long. Mounjaro, as a newer medicine, sits behind that queue in terms of NHS commissioning.

For people already on the NHS waitlist in Wales (or hoping to be referred) it is reasonable to discuss options with your GP. They can tell you whether your Local Health Board has commissioned relevant services, what the likely timeline is, and whether you meet the criteria that would apply once tirzepatide becomes available. It is also reasonable, in the meantime, to understand the difference between the NHS England rollout and provision elsewhere in the UK, so you're not waiting under a false impression of what's coming.

The human side of this: for people who have been managing their weight for years and are now watching a medicine that could genuinely help sit just out of reach behind a commissioning timeline, the frustration is real. It's one of the most common things our prescribers hear from patients in Wales.

Private Mounjaro in Wales: what the route actually looks like

Because NHS commissioning hasn't moved yet, private prescription is the practical route for most eligible adults in Wales who want to start tirzepatide now. A private prescription requires a full clinical assessment, a prescriber must review your health history, medications, BMI, and any relevant conditions before approving treatment. There are no shortcuts here; Mounjaro is a prescription-only medicine regardless of whether the prescription is NHS or private.

The private eligibility criteria broadly mirror the licensed indications in Mounjaro's SmPC: adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. Meeting the BMI figure doesn't guarantee a prescription, the prescriber weighs the full picture.

Through a GPhC-registered online pharmacy, the process can move quickly. You can verify any registered pharmacy using the GPhC pharmacy register. If you're thinking about ordering around a busy period (end of month when payday has just landed, a bank holiday week, or a Monday after a long weekend) checking whether the pharmacy dispatches same day and what the delivery window looks like is worth doing before you submit your consultation. Details like that make a practical difference to how quickly treatment starts.

For a fuller look at the cost side of private treatment, our overview of Mounjaro pricing in the UK explains what a legitimate private price includes and what it doesn't. On safety: only buy through a pharmacy you can verify. The MHRA has warned publicly about counterfeit weight-loss pens sold without a prescription through social media and unverified websites, fake pens have caused hospitalisations. If a price looks too low or a seller isn't on the GPhC register, that's a serious red flag.

How to move forward if you're in Wales

Your first step is a conversation with your GP. Even if NHS Wales hasn't commissioned tirzepatide yet, a GP can document your BMI and health conditions, discuss whether a specialist referral is appropriate, and help you understand your NHS options. That record can also be useful if you pursue a private route and want your GP kept informed, which is in line with GPhC guidance on GP notification. Our overview of Mounjaro and GP prescribing covers what that conversation typically covers.

If you're considering the private route, starting a free online consultation is straightforward. A GPhC-registered Independent Prescriber reviews your answers, not a piece of software. If approved as clinically suitable, treatment can be dispatched the same day and delivered free to your door the next working day. You can read more about how NHS access works across the UK, explore what buying Mounjaro through the NHS actually involves and whether it applies to your situation, or look at weight-loss treatment options more broadly before deciding what's right for you. There's no obligation in starting a consultation, and it answers the eligibility question definitively.